Renaissance Technologies’s XBiotech XBIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$95.8K Buy
41,663
+19,225
+86% +$46.5K ﹤0.01% 2984
2026
Q1
$52.7K Buy
+22,438
New +$54.3K ﹤0.01% 3106
2023
Q4
Sell
-15,287
Closed -$63K 4201
2023
Q3
$63K Sell
15,287
-13,048
-46% -$65.3K ﹤0.01% 3355
2023
Q2
$168K Sell
28,335
-24,160
-46% -$109K ﹤0.01% 3333
2023
Q1
$181K Sell
52,495
-48,973
-48% -$182K ﹤0.01% 3320
2022
Q4
$356K Sell
101,468
-54,000
-35% -$184K ﹤0.01% 3151
2022
Q3
$563K Buy
155,468
+76,800
+98% +$362K ﹤0.01% 2860
2022
Q2
$443K Buy
+78,668
New +$529K ﹤0.01% 3226

Other funds holding XBIT

Renaissance Technologies's XBIT Position: Q2 2026 in Review

Renaissance Technologies increased its XBiotech (XBIT) stake by 86% in Q2 2026, buying an estimated $46.5K and bringing the position to 41,663 shares worth $95.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2984.

Renaissance Technologies first reported a position in XBIT in Q2 2022 and has held it in 8 quarters since. The position peaked at $563K in Q3 2022. 36 funds tracked by Wall St. Rank hold XBIT as of Q2 2026.

  • Renaissance Technologies held 41,663 shares of XBiotech worth $95.8K as of Q2 2026.
  • Renaissance Technologies bought 19,225 XBiotech shares in Q2 2026, an estimated $46.5K.
  • XBiotech made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #2984 holding.
  • Renaissance Technologies first reported a position in XBiotech in Q2 2022 and has held it in 8 quarters since.
  • Renaissance Technologies's XBiotech position peaked at $563K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held XBiotech as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.